Biocardia, Inc. (BCDA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Biocardia, Inc. on October 7, 2025. The filing announces the scheduling of the Company's 2025 Annual Meeting of Stockholders and provides specific deadlines for shareholder proposals and director nominations.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and meeting logistics rather than financial performance.
Material Changes
There are no material changes to financial operations or business strategy reported in this filing. The primary update is the establishment of the Annual Meeting date and the associated record date for voting eligibility.
Guidance, Outlook, and Corporate Actions
- Annual Meeting Date: Tuesday, December 2, 2025, at 9:00 a.m. Pacific Time.
- Location: Wilson Sonsini Goodrich & Rosati, P.C., 650 Page Mill Road, Palo Alto, California.
- Record Date: October 8, 2025 (close of business).
- Proposal Deadline: October 17, 2025, for stockholder proposals to be included in the proxy statement or for nominations of directors.
- Universal Proxy Rules: Stockholders soliciting proxies for nominees other than the Board's must provide notice by October 17, 2025.
Key Facts for Investor Verification
- Verify the record date of October 8, 2025, to confirm eligibility to vote at the December 2, 2025, Annual Meeting.
- Note the October 17, 2025, deadline for submitting any shareholder proposals or director nominations.
- Confirm the physical location of the meeting in Palo Alto, California, as attendance instructions will be detailed in the upcoming proxy statement.
- Review the Company's amended and restated bylaws for specific requirements regarding proposal content and director nomination procedures.